Trials / Completed
CompletedNCT01899677
The Efficacy of Symbiotic on Cytokines
The Efficacy of Symbiotic Preparation on Cytokines Which Act on Necrotising Enterocolitis Pathogenesis in Very Low Birth Weight Infants
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
- Sex
- All
- Age
- 1 Hour – 2 Days
- Healthy volunteers
- Accepted
Summary
The aim of this prospective double blinded randomised study is to investigate the efficacy of symbiotic preparation which contains lactobacillus casei, L. rhamnosus, L. plantarum, Bifidobacterium lactis, fructo and galactooligosaccharide on cytokines as interferon-gama acting on Th1 pathway, interleukin -5 acting on Th2, interleukin -10 acting on T regulatory pathway, and interleukin -17 acting on Th-17 pathway that were related with necrotizing enterocolitis pathogenesis in very low birth weight neonates.
Detailed description
Inclusion criteria: 1. Neonates who born 26- 32 gestational week and 750-1500 gram birth weights 2. Neonates who tolerated minimal enteral feeding within postnatal first week Exclusion criteria: 1. PROM\> 24 hours and/or chorioamnionitis 2. Mechanic ventilation supply more than 7 days 3. Culture proven sepsis 4. Major congenital anomaly 5. Patients undergoing surgery Intervention: The allocations will contain in opaque, sequentially numbered sealed envelopes. The study group will receive symbiotic preparation (Probiotic ATP, Nobel, 1/2 sachet twice daily); whereas the control group will receive placebo (distilled water; 1 ml per dose twice daily) which will be added to breast milk or formula starting with the first feed.0.5 cc blood sampling will be taken from patients within postnatal 48 hours, 14+2.days, 28+2.days. This samples will turn by cold centrifugation and store at -20 °C temperature. The cytokines will be analysed by ELISA multiplex method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | distilled water | 0.5 cc distilled water twice daily will be added to the breast milk or formula during 30 days |
| DRUG | symbiotic | Symbiotic 1/2 sachet twice daily will be added to the breast milk or formula during 30 days |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2013-07-15
- Last updated
- 2014-08-08
- Results posted
- 2014-08-06
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01899677. Inclusion in this directory is not an endorsement.